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Abstract
Background: Schistosomiasis is one of the most harmful parasitic diseases worldwide, praziquantel being the only
drug in widespread use to treat it. We recently demonstrated that ferrocenyl, ruthenocenyl and benzyl derivatives
of oxamniquine (Fc-OXA, Rc-OXA and Bn-OXA) are promising antischistosomal drug candidates.
Methods: In this study we assessed the tegumental damage of these three derivatives of oxamniquine using
scanning electron microscopy. Adult Schistosoma mansoni and S. haematobium were exposed to a concentration of
100 μM of each drug and incubated for 4–120 h, according to their onset of action and activity.
Results: While on S. mansoni the fastest acting compound was Fc-OXA, which revealed high activity after 4 h of
incubation, on S. haematobium, Rc-OXA revealed the quickest onset, being lethal on all males within 24 h. In both
species studied, the three derivatives showed the same patterns of tegumental damage consisting of blebs,
sloughing and tegument rupturing all over the body. Additionally, on S. mansoni distinct patterns of tegumental
damage were observed for each of the compounds: tissue ruptures in the gynaecophoric canal for Fc-OXA, loss of
spines for Rc-OXA and oral sucker rupture for Bn-OXA.
Conclusions: Our study confirmed that Fc-OXA, Rc-OXA and Bn-OXA are promising broad spectrum
antischistosomal drug candidates. All derivatives show fast in vitro activity against S. mansoni and S. haematobium
while validating the previous finding that the parent drug oxamniquine is less active in vitro under the conditions
described. This work sets the base for further studies on the identification of a lead oxamniquine derivative, with
the aim of identifying a molecule with the potential to become a new drug for human use.
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Background
Schistosomiasis is a human parasitic disease that af-
fected 230 million people worldwide in 2014 [1] and
is caused by the infection with one or more of the
six Schistosoma species: Schistosoma mansoni, S. hae-
matobium, S. japonicum, S. mekongi, S. intercalatum
and S. guineensis; the first three are the most import-
ant human species [1]. Because no vaccine is avail-
able, and the use of molluscicides to control the
intermediate host is difficult to conduct, the most
commonly used strategy to control the disease is pre-
ventative chemotherapy through large-scale adminis-
tration of praziquantel [2]. Praziquantel, developed in
the 1970’s, is safe and effective, but has some short-
comings: the tablets are big because of the large dose
needed, it is very bitter [3] and the drug is not active
against juvenile forms of the parasite [4]. Frequent
retreatment of patients is therefore required to target
all parasite stages. Oxamniquine (OXA) is a drug that
was developed in the 1960’s [5] and proved to be ef-
fective and safe, but has two shortcomings: it is only
active against S. mansoni [5–7] and resistance devel-
oped quickly due to punctual mutations to the en-
zyme’s active site [8]. OXA is a pro-drug that for
activation needs to be taken up by the worm and
sulfonated by a sulfotransferase (SmSULT) to an un-
stable intermediate that spontaneously decays to a
highly electrophilic molecule that alkylates DNA, pro-
teins and macromolecules, thus interfering with its
metabolic functions and killing the parasite [9]. En-
zyme orthologs are present also in S. japonicum and
S. haematobium and in mammalian cells, but differ-
ences in the interaction in the active site prevent the
activation of the molecule (70% protein sequence
homology between S. haematobium and S. mansoni)
[9]; therefore the drug is not active against S. haema-
tobium [6]. The SmSULT expression in juvenile stages
of the parasite has not yet been studied; however,
OXA is known to be only slightly active against larval
stages of S. mansoni [10]. Aiming to overcome this
species and stage specificity through improved
interaction with the target enzyme, we previously
tested six OXA derivatives primarily based on organo-
metallic derivatization due to its medicinal potential [11,
12] and identified three molecules (ferrocenyl, ruthenoce-
nyl and benzyl derivatives of oxamniquine, named
Fc-OXA, Rc-OXA and Bn-OXA, respectively) (Fig. 1)
with a promising in vivo and in vitro activity profile
against S. mansoni. Importantly, these compounds also
displayed activity in vitro against S. haematobium [11].
The aim of the present study was to assess the damage
to the tegument of S. mansoni and S. haematobium, evi-
denced by scanning electron microscopy (SEM) follow-
ing incubation with Fc-OXA, Rc-OXA and Bn-OXA at
the time points where the in vitro viability of the worms
was markedly affected. Considering the importance of
the tegument for schistosomes, which allows them to
evade the immune response of the host, SEM is a
valuable approach to identify whether the molecules can
induce damage to this critical structure [13], and hence
expose immune-reactive molecules and trigger an im-
mune response in the host.
Methods
Adult S. mansoni worms
Three week-old female NMRI mice (n = 7) were pur-
chased from Charles River and were allowed to
acclimatize for one week. They were infected by a sub-
cutaneous injection in the back of the neck with ap-
proximately 100 cercariae and kept in the animal facility
of the Swiss TPH for 49 days to allow the infection to
develop into the adult stage. Mice were then euthanized
by the CO2 method and worms were collected by
picking them from the hepatic portal system and mes-
enteric veins. Worms were washed in culture medium
at room temperature and incubated at 37 °C with 5%
CO2 until use (no longer than 2 days). The medium
consisted of RPMI 1640 culture medium (Gibco -
Thermofisher, Waltham, MA USA) supplemented with
1% penicillin/streptomycin (BioConcept, Allschwil,
Switzerland) and 5% Fetal Calf Serum (FCS) (BioCon-
cept). Eight to ten worms of both sexes per time
Fig. 1 Molecular structure of the derivatives of oxamniquine. a Ferrocenyl oxamniquine. b Ruthenocenyl oxamniquine. c Benzyl
oxamniquine
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point were incubated in the described medium, in the
presence of 100 μM [11] of each of the three deriva-
tives (Fc-OXA, Rc-OXA, Bn-OXA) and oxamniquine.
The control consisted of 8–10 worms incubated in
culture medium spiked with dimethyl sulfoxide
(DMSO) at a concentration of 1%, equivalent to the
content of DMSO present in the wells of treated
worms. Worms were monitored daily, scoring motility,
viability and morphological alterations under a bright
field inverted microscope (Carl Zeiss Oberkochen,
Germany, magnification ×4 and ×10) as described
elsewhere [14]. The scoring scale ranges from 3 to 0
with a 0.25 interval. The score 3 corresponds to fully
vital worms showing normal movement and activity,
and no morphological changes; 2 is assigned to slowed
worm activity, first morphological changes (loss of
attachment to the well plate, suckers deformity) and
visible granularity; 1 is given if minimal activity, severe
morphological changes (change of the color, loss of
transparency, rounded body disposition) and marked
granularity is observed; and 0 refers to dead worms reveal-
ing severe granularity.
Worms were collected for SEM analysis at the time
point when the average viability of the worms was visibly
affected. For each compound the onset of action was
different, therefore the time points range from 4 h for
Fc-OXA, to 24 h for Rc-OXA, to 72 h for Bn-OXA and
120 h for OXA.
Adult S. haematobium worms
One month-old male LVG hamsters (Charles River, NY)
(n = 4) were exposed to 350 S. haematobium cercariae
at the Biomedical Research Institute in Rockville, USA
(NR-21964), and shipped to the Swiss TPH where the
infection was allowed to develop for three months until
chronic infections had been established. The animals
were kept in the animal facility until use, for a max-
imum of four months. Hamsters were euthanized by
the CO2 method and worms picked from hepatic
portal system and mesenteric veins. Briefly, 8–10 adult
S. haematobium were exposed to a 100 μM concentra-
tion for 24 h for ruthenocenyl oxamniquine, 48 h for
ferrocenyl and benzyl oxamniquine and 120 h for oxamni-
quine, depending on the time needed for the worms to
show a marked decrease in viability. Media used and
scoring procedure were conducted as described for
S. mansoni worms.
Fig. 2 SEM images of S. mansoni control worms incubated with 1% DMSO. a Tubercles of dorsal mid-part of a male. b Lateral mid-part of a male
showing the transition between the tubercles of the dorsal side to the spiny ridges of the ventral side of the body. c Head of a male showing
the oral and ventral suckers and the gynaecophoric canal. d Mid-part of the body of a female showing the ridges and pores in a context of a
smooth tegument. Abbreviations: GC, gynaecophoric canal; OS/VS, oral/ventral sucker; P, pores; R, ridges; S, spines; T, tubercles. Scale-bars: a, 10
μm; b, 20 μm; c, 200 μm; d, 50 μm
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Oxamniquine derivatives
Oxamniquine was kindly donated by Pfizer (New York
City, USA) while the Fc-OXA, Rc-OXA and Bn-OXA
were prepared starting from oxamniquine, as described
previously [11].
SEM images
Following the in vitro cultivation of the worms with
the compounds as described above, S. mansoni and
S. haematobium worms were rinsed twice in PBS,
and fixed in 1 ml glutaraldehyde 2.5% for 4 h at
room temperature. Worms were then sequentially
dehydrated by incubation for 30 min in increasing
concentrations of ethanol in deionized water (30, 50,
70, 90 and 100%) and kept in the fridge in 100%
ethanol until use. For imaging, worms were critically
point-dried (Bomar SPC-900, Washington, USA),
mounted on aluminum stubs and sputter-coated with
gold of 20 nm particle size (Leica EM ACE 600,
Heerbrugg, Switzerland). Samples were visualized
using a high-resolution SEM accelerating voltage of
5 kV (Philips XL30 ESEM, Bruchsal, Germany). Con-
trol worms were prepared and visualized in the same
manner. All images were taken in the Nano Imaging
Lab, SNI, University of Basel.
IC50 value calculations
The IC50 values of each of the derivatives against S. hae-
matobium were calculated using the software CompuSyn
1.0 (ComboSyn Inc, 2007) after 72 h of incubation with
the following concentrations of each drug: 100, 50, 25,
12.5 and 6.25 μM. The equation to normalize the score
of the treated worms to the controls and calculate the
effect was:
Effect ¼ 1 Average scoretreatment=Average scorecontrol
 
The IC50 values obtained for the drugs on S. mansoni
are described elsewhere [11].
Results and discussion
Studies on S. mansoni
Figure 2a and b shows the tegument of healthy adult
S. mansoni males depicting ridges and tubercles covered
Fig. 3 Adult S. mansoni exposed to 100 μM Fc-OXA incubated for 4 h. a Tissue sloughing from the lateral side of the mid-part of the
body of a male and exposure of sub-tegumental tissue. b Mid-part of the body of a male showing the lateral side with ruptures, the
gynaecophoric canal and ruptured tissue on the other side of the canal. c Blebs and ruptures in the inner side of the gynaecophoric
canal, mid-part of the body. d Upper part of the body of a female showing tissue sloughing off and blebs on the tegument and
ventral sucker. Abbreviations: B, blebs; GC, gynaecophoric canal; R, rupturing; S, sloughing off; VS, ventral sucker. Scale-bars: a, b, d,
50 μm; c, 20 μm
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by spines that are more or less uniformly distributed. In
Fig. 2c the oral and ventral suckers and the gynaecopho-
ric canal of control worms are shown. Ridges are also
present on females, but no tubercles or spines; instead,
the teguments of the female look more porous and
smooth (Fig. 2d).
After 24 h and 48 h of exposure to a 100 μM con-
centration of oxamniquine, the worms were alive and
phenotypically in a good shape (score above 2) and
we did not evidence any damage to the tegument by
means of SEM (not shown). After exposure for 120 h
we observed loss of attachment to the well, slight
blebbing on the tegument and reduction of movement
of the treated worms when compared to the control
group. Since the controls also showed mild blebbing
and sloughing tissue after this long incubation, we
were not able to correlate a certain pattern of damage
with the exposure of the worms to OXA. Our data
confirm previous findings of OXA being only slightly
active in vitro [11] and the difficulties to maintain the
worms for long incubation periods where they start
revealing tegument damage [15].
Fc-OXA produced after four hours of exposure at a
100 μM concentration extensive blebs, sloughing and
rupture of the tegument along the whole dorsal body
surface on all worms examined (Fig. 3a–c). Along the
gynaecophoric canal blebbing and sloughing tissue was
evident (Fig. 3c). On the males, no damage to the
suckers was observed and the spines did not look signifi-
cantly damaged (not shown), but were partially covered
by the tissue that was detaching, as can be seen in
Fig. 3a. On the females, the damage was principally
focused on the upper part of the body, where Fc-OXA
produced sloughing off and blebbing on the tegument and
the ventral sucker (Fig. 3d).
Four hours after exposure to Rc-OXA, the pheno-
typic score of the worms averaged 0.81 ± 0.15 (n = 8,
all worms alive) yet only mild tegumental damage
was observed by means of SEM, which consisted of
loss of spines and mild blebs in the male, but no
damage was evidenced in the females (not shown).
After 24 h of incubation, the male worms had died
and the females showed significant morphological
changes, very low motility and the maximum score
observed was 0.25. Tegumental damage of the males
consisted of increased loss of spines (Fig. 4a) accom-
panied by tegument sloughing, blebs and vesicle forma-
tion all over the body surface (Fig. 4a–c). Although the
viability score of the females was below 0.5, no pro-
nounced tegumental damage could be evidenced using
Fig. 4 Adult S. mansoni exposed to 100 μM Rc-OXA for 24 h. a–c Dorsal mid-part of males showing blebs, sloughing tissue and loss of spines. d
Mid-part of the body of a female showing undamaged ridges and very mild damage characterized by blebs along the body. Abbreviations: B,
blebs; LS, loss of spines; R, ridges; S, sloughing off. Scale-bars: a–c, 20 μm; d, 30 μm
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SEM (Fig. 4d). The oral and ventral suckers did not show
significant damage and most couples stayed together
during drug exposure (not shown) despite death of
the male worms. We have no explanation for this obser-
vation, but it is possible that the females showed very low
vitality and eventually were not able to dissociate from
the dead male.
Bn-OXA produced minor damage to the tegument
24 h after incubation, which consisted of small dimples
(Fig. 5a). Only after 72 h of drug exposure the tegumental
damage became evident and consisted, similar to
Fc-OXA and Rc-OXA, of blebs (Fig. 5b), sloughing
and tegumental rupture distributed all over the dorsal
surface (not shown). At this time point, eight worms
were dead (5 females, 3 males) while five were still
alive but highly affected (scoring below 1). Of the
three candidates tested, Bn-OXA was the one which
showed the most visible damage to the females, which
consisted of tegumental rupture (Fig. 5c) and loss of
uniformity on the ridges (Fig. 5d), and surprisingly
was the only compound with slightly more activity on
females than on males within 72 h of drug exposure.
Additionally, Bn-OXA was the only compound that
produced loss of spines from the ventral sucker and
erosion in the oral sucker of S. mansoni (Fig. 5e, f ).
Table 1 summarizes IC50 values [11], onset of action
and key tegumental changes for all compounds exam-
ined on S. mansoni. Bn-OXA had the slowest onset
Fig. 5 Adult S. mansoni exposed to 100 μM Bn-OXA. a Dorsal mid-part of a male exposed for 24 h showing very mild damage. b Dorsal mid-part
of a male’s body incubated for 72 h. c, d Mid-part of female exposed for 72 h showing tegument ruptures and loss of uniformity of the ridges. e,
f Head of males exposed for 72 h showing loss of spines from the ventral sucker and rupture and occlusion of the oral sucker. Abbreviations: B,
blebs; D, dimples; LS, loss of spines; OS/VS, oral/ventral sucker; R, ridges; S, sloughing off; Scale-bars: a, c, 10 μm; b, d, 20 μm; e, 60 μm; f, 50 μm
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of action, which slightly contradicts the results pre-
sented by Hess et al. [11] who described 80%
reduction in viability already after 24 h and 100% ef-
fect (all worms dead) in 72 h. The qualitative changes
observed differ between the compounds studied and
between males and females, a finding which is not
uncommon for antischistosomal drugs. Artemether
for example, causes extensive peeling in females but
not in males [16]. Overall, the tegumental changes
observed resemble findings from previous studies with
praziquantel and other lead candidates, which also
mention loss of spines, blebs and sloughing tissue
with exposure of sub-tegumental tissue [17, 18].
Studies on S. haematobium
Figure 6 depicts images of control S. haematobium.
Ridges and tubercles with spines on the dorsal side of
the tegument and spines uniformly distributed in the
gynaecophoric canal are visible (Fig. 6a, b). The
apexes of the tubercles of male S. haematobium are
free of spines (Fig. 6c). The tegument of the females
also presents ridges, looks smoother than the males
Table 1 Comparative activity and effect of the OXA derivatives against S. mansoni
Compound S. mansoni adult 72
h IC50 (μM)
Onset
of action 100 μM (h)
Most
affected sex
Tegumental damage
Blebbing Sloughing off Specific damage pattern/organ
Fc-OXA 11.4a 4 Males + ++ Gynaecophoric canal
Rc-OXA 8.7 a 24 Males ++ + Loss of spines
Bn-OXA 11.1 a 72 Females + +++ Suckers
OXA > 100 120 Both β β β
Abbreviation: β, no difference was observed to control group
aHess et al. [11]
Fig. 6 Control group of adult S. haematobium. a Head of a male showing oral and ventral suckers and the gynaecophoric canal. b Dorsal
and lateral side of a male with tubercles and ridges. c Dorsal side of the mid-part of male showing ridges, sensory papillae and apex-
spine-free tubercles. d Mid-part of the body of a female revealing the smooth tegument with ridges and sensory papillae. Abbreviations:
GC, gynaecophoric canal; OS/VS, oral/ventral sucker; P, papillae; R, ridges; SFA, spine free apex; T, tubercles. Scale-bars: a, 200 μm; b,
50 μm; c, 20 μm; d, 50 μm
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and the sensory papillae are uniformly distributed all
over the body (Fig. 6d).
As observed for S. mansoni, S. haematobium incu-
bated for 120 h in 1% DMSO also showed slight tegu-
mental damage, characterized by blebs and sloughing
tissue (not shown). Therefore few conclusions can be
drawn with regard to the damage of 100 μM OXA incu-
bated for 120 h. However one sign of damage could be
related to OXA, due to the fact it was not evidenced in
any of the controls: worms incubated with OXA for 120
h showed invagination of the ventral sucker in females
and erosion of the oral sucker in both sexes (Fig. 7a, b).
Fig. 7 Schistosoma haematobium exposed to 100 μM OXA for 120 h. a Head of a female showing the invaginated ventral sucker.
b Head of a female showing the invaginated ventral sucker and mild damage to the oral sucker consisting of blebs and the
oral sucker of a male, also showing small ruptures and blebs. Abbreviations: OS, oral sucker; Po, pores; VS, ventral sucker.
Scale-bars: 50 μm
Fig. 8 Adult S. haematobium exposed to 100 μM Fc-OXA for 48 h. a Dorsal mid-part of the body of a male showing early rupturing around the
tubercles. b Tegument sloughing at the dorsal mid-part of the body and the gynaecophoric canal. c Blebs on the dorsal mid-part of the body of
a male. d Tegument of a female showing normal ridges and papillae, but also pores; pores seem to be present in higher quantity than in the
control group. Abbreviations: B, blebs; GC, gynaecophoric canal; P, papillae; Po, pores; R, rupturing; S, sloughing off. Scale-bars: a, 50 μm; b, 200
μm; c, 20 μm; d, 30 μm
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Additionally, we observed a higher number of pores in
both sexes of the treated worms with respect to the con-
trols (Fig. 7a).
After 48 h of exposure to 100 μM Fc-OXA we ob-
served damage to the tegument and the gynaecophoric
canal along the entire body, which, as in S. mansoni,
consisted of blebbing and sloughing off (Fig. 8a–c).
The sloughing tissue started its rupture from the
areas surrounding the tubercles (Fig. 8a). Compared
to the damage of this compound to the gynaecophoric
canal in S. mansoni, the damage to this part of the
body in S. haematobium was more pronounced
(Fig. 8b). In females, appearance of pores over all the
tegument (Fig. 8d), sporadic blebs and sloughing tissue
(not shown) was visible. Damage to the oral or ventral
suckers was not seen for Fc-OXA and the overall damage
observed was more evident in males than in females.
The treatment of S. haematobium with Rc-OXA pro-
duced, as in S. mansoni, rupture of the tegument, with
blebs and sloughing of tissue, and loss of spines within 24 h
of incubation (Fig. 9a–c). In the females (Fig. 9d) we
observed damage limited to small ruptures not related to
any specific section or structure of the body despite that
the viability of both male and female worms had decreased
to a score below 0.5, revealing high activity of the drug. We
could not evidence damage to the suckers or gynaecophoric
canal following exposure to this compound either in males
or in females.
Following incubation of S. haematobium males with
Bn-OXA, creases of the inner and outside of the body
were visible after 48 h of exposure and there was a ten-
dency of the worms to die in a circular body disposition
(Fig. 10a). As in S. mansoni and Fc-OXA and Rc-OXA
on S. haematobium, bleb/vesicles formation was a com-
mon phenomenon that appeared in large quantities on
the entire surface of the tegument (Fig. 10b, c). With
regard to tegumental sloughing, the effect of Bn-OXA
against S. haematobium was much milder (Fig. 10b, c)
when compared to the other compounds (Figs. 8b, 9b)
and exposure of S. mansoni to Bn-OXA (Fig. 5c, f ). We
did not evidence damage to the suckers of the males
following exposure to Bn-OXA. However, in females, the
erosion and deformity to both oral and ventral suckers
was significant (Fig. 10d) and was also accompanied by
sloughing tissue.
Different from the activity of Bn-OXA against S. mansoni,
in S. haematobium this compound was more active against
males than against females, but as for S. mansoni, Bn-OXA
seemed to reveal the highest activity of the three derivatives
against females.
Table 2 summarizes in vitro effects of the three com-
pounds on S. haematobium. After exposure to a 100 μM
Fig. 9 Adult S. haematobium exposed to 100 μM Rc-OXA for 24 h. a–c Dorsal mid part of the body of a male showing blebs, tissue rupture and
loss of spines. d Mid-part of the body of a female showing the tegument rupture. Abbreviations: B, blebs; LS, loss of spines; P, papillae; R, ruptures.
Scale-bars: a–c, 50 μm; d, 20 μm
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concentration, Fc-OXA needed 48 h to trigger a reduc-
tion in viability of 75–85% on S. haematobium, while
Rc-OXA was lethal for all males and reduced the viabil-
ity of the females to a score lower than 0.5 within 24 h.
Rc-OXA also had the lowest IC50 value of the three
compounds. Bn-OXA reduced the viability of males and
females by 70% within 48 h. All derivatives were more
active on males than on females, while in the case of
oxamniquine no difference of sex susceptibility could be
determined. Also, for S. haematobium we observed loss
of spines and sloughing tissue, which are signs of drug
activity that have been described before, for example for
artemisinins against S. haematobium [19]. Other studies re-
ported the damage of active compounds to S. haematobium
to be characterized by edematous intertubercular spaces
and collapse of tubercles, signs that were not observed in
our compounds [20].
Comparison of oxamniquine derivatives
While the fastest and most active compound against
S. mansoni was Fc-OXA, Rc-OXA was the most
promising compound for S. haematobium with re-
gard to in vitro activity and tegumental damage. Sur-
prisingly, Fc-OXA had the highest IC50 value against
S. haematobium. Bn-OXA was the compound with
the slowest visible effect against both species, but was
active against both species as well, in a timeframe of
48–72 h, depending on the species. Overall, a higher
activity of the derivatives was observed against S. mansoni
than against S. haematobium.
Fig. 10 Adult S. haematobium exposed to 100 μM Bn-OXA for 48 h. a Male showing creases of the tegument and the circular disposition of the
body before dying. b, c Dorsal mid-part of male’s tegument showing the extensive distribution of blebs, vesicles and mild sloughing off. d Head
of a female showing extensive erosion of the oral sucker and extensive deformity of the ventral sucker. Abbreviations: B, blebs; C, creases; OS/VS,
oral/ventral sucker; SFA, spine free apex; V, vesicles. Scale-bars: a, 600 μm; b, 10 μm; c, d, 50 μm
Table 2 Comparative activity and effect of the derivatives against S. haematobium
Compound S.
haematobium
adult 72 h IC50 (μM)
Onset
of action 100 μM (h)
Most
affected sex
Tegumental damage
Blebbing Sloughing off Specific damage pattern/organ
Fc-OXA 68.1 48 Males + ++ Gynaecophoric canal
Rc-OXA 24.5 24 Males ++ ++ Loss of spines
Bn-OXA 38.6 48 Males + +++ Body creases
OXA > 100 120 Both + β VS invagination
Abbreviations: VS, ventral sucker; β, no difference was observed to control group
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For both species, and all three derivatives investigated,
we could observe common patterns of damage to the
tegument, which consisted of extensive blebs and con-
siderable tegument rupture and sloughing off along the
whole body, with exposure of sub-tegumental tissue.
The sub-tegument might expose antigens and therefore
trigger an immune response attack, commonly observed
for antischistosomal drugs [17–19].
Differences in the damage distribution cannot be ex-
plained, but might be due to a differential distribution of
the activating enzyme in the body of the parasites or
additional mechanisms of action for the individual deriv-
atives supporting the antiparasitic effect.
Conclusions
Our study confirmed that Fc-OXA, Rc-OXA and
Bn-OXA are promising broad spectrum antischistosomal
drug candidates. All derivatives showed high in vitro
activity against S. mansoni and S. haematobium, while
validating the previous finding that the parent drug
oxamniquine is less active in vitro under the conditions
described. Future studies should aim to further
characterize these compounds, taking into account the
in vivo activity on juvenile stages of development and
activity against S. haematobium in vivo.
Abbreviations
OXA: Oxamniquine; Fc-OXA: Ferrocenyl oxamniquine; Rc-OXA: Ruthenocenyl
oxamniquine; Bn-OXA: Benzyl oxamniquine; SEM: Scanning electron
microscopy; SmSULT: Schistosoma mansoni sulfotransferase; DMSO: Dimethyl
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